Clinical trial · Observational
Oral Chemotherapy and Quality of Care
Community and Hospital Experiences for Patients Treated by Oral Chemotherapy at the University Hospital of Caen: Analysis of the Process and Its Dysfunctions
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
PARCOURS is a non-interventional research study evaluating dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy (60 patients followed for 3 months). References used are the National Cancer Institute recommendations for the oral chemotherapy treated outpatients. Parameters found are : information exchanged, ambulatory and hospital monitoring in case of adverse event and adherence to treatment. The study includes also a medico-economic evaluation (hospitalization and transport spending in case of dysfunction in the patient's journey). Deviations will be analyzed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of dysfunctions
- timeFrame
- 3 months
- description
- Number of dysfunctions objectified during the 3-month follow-up period, by sub-processes of the course
Secondary outcomes (8)
- measure
- Drug adherence
- timeFrame
- 3 months
- description
- measured by Morisky-Green's questionnaire to the patient
- measure
- Drug adherence
- timeFrame
- 3 months
- description
- measured by Data on the refill of prescriptions with the National Health Insurance, and evaluated according to the Drug Possession Ratio
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient over 18 years old * Suffering from cancer (hematological malignancies, digestive tumors, thoracic tumors or cutaneous tumors) * With an oral anticancer chemotherapy initial prescription written by an oncologist or hematologist from the University Hospital of Caen, whatever the place of the drug dispensing (Community pharmacy or hospital pharmacy ) Exclusion Criteria: \- Patient treated by oral anticancer chemotherapy for another pathology
References
Publications (0)
Data not yet available